Jemlani, Sauda M.

HRN: 29-21-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
CEFUROXIME 1.5GM (VIAL)
06/22/2026
06/24/2026
IVTT
1.5g
Q8h
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: